Mineralized matrix formation is a well-orchestrated event requiring several players. 
ABSTRACT:
Mineralized matrix formation is a well-orchestrated event requiring several players. Glucose regulated protein-78 (GRP-78) is an endoplasmic reticulum chaperone protein that has been implicated in functional roles ranging from involvement in cancer biology to serving as a receptor for viruses. In the present study, we explored the role of GRP-78 in mineralized matrix formation. We observed changes in the expression of GRP-78 mRNA and protein upon in vitro differentiation of primary mouse calvarial cells. We also observed GRP-78 in the secretome of these cells suggesting an extracellular function during matrix formation.
In-vitro nucleation experiments under physiological concentrations of calcium and phosphate ions indicate that GRP-78 can induce the formation of calcium phosphate polymorphs both by itself and when bound to type I collagen. We provide evidence that secreted GRP-78 can bind to DMP1 and Type I collagen independent of each other. Finally, we demonstrate that GRP-78 functions as a receptor for DMP1 endocytosis in pre-osteoblasts and primary calvarial cells. Our findings provide the proof of principle that that besides an intracellular function, GRP-78 plays a regulatory role during mineralized matrix formation.
Introduction:
GRP-78, also known as hspa5, is a member of the heat shock protein 70 (HSP 70) family. Its primary function is to act as a molecular chaperone in the endoplasmic reticulum (ER) and facilitates the proper folding and assembly of membrane and secretory proteins.
However, GRP-78 is upregulated under stress conditions such as glucose deprivation and presence of toxic agents [1] [2] [3] [4] . GRP-78 has been reported to be translocated to the detergent resistant fractions of the plasma membrane of these cells [5, 6] . It has also been implicated to function as a receptor for alpha 2-macroglobulin and different viruses through lipid rafts [7] [8] [9] . Interestingly, GRP-78 has been shown to possess calcium binding properties with reports of calcium binding affinity ranging from 1-2 moles of calcium per mole of GRP-78 to much larger quantities [10] . The biological significance of the calcium binding ability of GRP-78 is however, a subject of debate with its role primarily being attributed to binding of ER Ca 2+ similar to other sequestering proteins. Recent studies have shown that several stress proteins play a significant role in osteoblast differentiation. Specifically, OASIS, an ER stress transducer has been implicated to be involved in bone formation [11] . Additionally, a study on the analysis of the secretome of differentiating human mesenchymal stem cells showed an increase in the amount of secreted stress proteins [12] . This study quantitatively analyzed the presence of GRP-78 in the secreted pool of proteins and showed that the amount of protein increased when the cells were subjected to differentiation. Increase in expression of GRP-78 was attributed to a need for protein folding as protein synthesis increased upon induction of differentiation. However, this does not explain why an increased amount of secreted GRP-78 is present in differentiating mesenchymal cells. Despite extensive studies on the function of intracellular GRP-78, the expression and function of GRP-78 in the extracellular matrix, particularly with respect to mineralized matrix formation such as bone and teeth has not been reported. Recently, we have demonstrated that dentin matrix protein 1 (DMP1), an acidic phosphoprotein, initially identified from the extracellular dentin matrix and implicated in differentiation of mesenchymal cells and also in biomineralization [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] binds to GRP-78 found on the plasma membrane of odontoblasts and is endocytosed via the caveolar pathway [24] . In this study we show that a similar physiological process occurs in pre-osteoblasts and osteoblasts. Considering the extracellular presence of GRP-78, its calcium binding ability and the increase in extracellular protein levels during differentiation, we hypothesize that GRP-78 might play a regulatory role in mineralized matrix formation. Overall, we present evidence for a novel role for GRP-78 in osteoblasts and in the formation of mineralized matrix adding another facet to the multiple roles of this ER chaperone.
Materials and Methods:
Cell Culture: Three different cell types were used in this study. Two of them were established cell lines namely MC3T3-E1 mouse pre-osteoblast cell line (kind gift from Dr. Renny Francheschi) and Rat Marrow Stromal cell line (RMSC) (Tulane Cancer Centre). Both cell types were grown in alpha MEM media supplemented with 10% FBS (MC3T3-E1) or 20% FBS (RMSC).
Additionally, primary calvarial osteoblasts were obtained from 5 day old wild type CD-1 mice according to approved UIC Animal protocol (Assurance no: A3460.01) and cultured in alpha MEM media supplemented with 20% FBS and 1% penicillin streptomycin cocktail. When required differentiation media comprising of 10µg/ml ascorbic acid, 10mM β-glycerophosphate and 10nM ascorbic acid added to growth media was used.
When required serum free differentiation media was also used.
Expression and purification of DMP1 and GRP-78 recombinant proteins:
Recombinant DMP1 protein without any post-translational modifications was expressed and purified as published earlier [14] . Briefly, the DMP1 cDNA was amplified from the rat tooth germ without the signal peptide and cloned into pGEX-4T-3 vector (Invitrogen) and expressed as Glutathione-S-Transferase (GST) fusion proteins in BL21-DE3 cells. The fusion protein was then purified by binding to a glutathione sepharose column, cleaved using thrombin to remove the fusion tag and eluted through a benzamidine-sepharose column to remove thrombin. The recombinant full length GRP-78 was expressed as a His-tagged protein as described by Lamb et al [25] . Briefly, p6His-GRP-78 was expressed in Bl21-DE3 bacteria. The His-tagged protein was bound to a nickel column and the recombinant protein was eluted using 1M immidazole. The purity of both proteins were analyzed by SDS-PAGE (poly acrylamide gel electrophoresis).
Isolation and detection of GRP-78 in RNA, cytoplasmic and secreted proteins of MC3T3-E1 and primary calvarial cells: Primary calvarial cells were cultured to 80% confluency in 100 mm tissue culture dishes. The medium was then changed to osteogenic differentiation media (100µg/ml ascorbic acid, 10mM β-glycerophosphate and 10mM dexamethasone added to the growth media). The cells were cultured in osteogenic medium for 7, 14, and 21 days. Cells not exposed to osteogenic medium served as controls. RNA and cytosolic proteins from the cells were isolated using trizol (Invitrogen) reagent and M-PER extraction kit (Pierce) respectively according to manufacturer's protocol. The isolated proteins were resolved on SDS-PAGE and immunoblotting was performed with anti-GRP-78 and anti-tubulin (SIGMA) antibody as described previously. Densitometric analysis was performed on the immunoblots using Image J software with tubulin as normalization control. Expression of GRP-78 transcript was analyzed by qPCR using Taqman primers. Primers for GAPDH were used in the same reaction mixture and the data was normalized to the expression of GAPDH.
The experiments were performed in triplicates. MC3T3-E1 and mouse primary calvarial cells were grown to 80% confluence in their growth medium in T-75 tissue culture flasks. The medium was subsequently changed to serum free medium for a period of 48 hours. The media containing the secreted proteins was collected, centrifuged and dialyzed extensively against double deionized (DD) water. The dialyzed solution was then freeze dried and reconstituted in 500µl of PBS. 20µl of the protein was subjected to SDS-PAGE and transferred on to nitrocellulose membrane. Media was also collected from MC3T3-E1 cells cultured in the presence of differentiation media. For these experiments, the media was changed to serum free differentiation media 24 hrs prior to completion of the specified time point. Total proteins were resolved on SDS-PAGE and immunoblotting was performed with rabbit polyclonal anti-GRP-78 primary antibody (1/1000) and a corresponding anti-rabbit HRP conjugated secondary antibody.
In-vitro calcium phosphate nucleation:
The nucleation experiment was conducted as previously published [18] . Briefly, pretreated cover glass was adsorbed with protein solution containing 20µg of recombinant GRP-78 protein in 100µl of 25mM sodium bicarbonate buffer and incubated overnight at 4ºC in a humidified chamber.
Uncoated and 20µg BSA coated cover glass served as controls. Additionally, cover glass was also coated with type I collagen (25µg) as per manufacturer's instructions and then incubated with recombinant GRP-78 at saturation concentration (obtained from the binding experiment with GRP-78 and type I collagen) at 37ºC for 1 hour. Plates coated with type I collagen incubated with equivalent concentration of BSA served as controls. Demineralized dentin wafers (a gift from Dr. Anna Bedran Russo, UIC College of Dentistry) were incubated with 150µg of GRP-78 at 4ºC overnight. Uncoated and wafers coated with the same amount of BSA served as controls.
After incubation, the samples were rinsed with DD water and placed into a channel connecting two halves of an electrolyte cell, one compartment containing calcium buffer (165mM NaCl, 10mM HEPES, 2.5mM CaCl 2 , pH 7.4) and the other phosphate buffer (165mM NaCl, 10mM HEPES KH 2 PO 4 pH 7.4). A small electric current of 1mA was passed through the system to facilitate even distribution of the ions on the cover glass coated with the proteins. The buffers were changed regularly to maintain a constant pH. At the end of 7 days the cover glass was removed, washed and air-dried. The samples were then imaged using a Hitachi S-3000N variable pressure electron microscope. Energy dispersive X-ray analysis was also performed to analyze the presence of calcium and phosphorous ions.
Isolation of the ECM:
MC3T3-E1 cells were grown to confluence on cover glass. Cell lysis was performed while retaining the ECM intact according to published protocols [24] . The ECM was then fixed in 4% paraformaldehyde and subjected to immunostaining with anti-GRP-78 antibody.
GRP-78 and type I collagen binding solid phase assay:
5µg of rat tail type I collagen (BD Biosciences) was coated onto 96 well plate according to the manufacturer's protocol. The wells were subsequently blocked for 1 hour at room temperature with 5% BSA in PBS and incubated with increasing concentrations of recombinant GRP-78 protein for a period of 1 hour at 37ºC. Incubation was also performed with varying amounts (20, 50 and 100µl) of secreted proteins from MC3T3-E1 cells cultured for 21 days in growth media and differentiation media respectively. The incubation was performed overnight at 4ºC for these samples. After incubation, the wells were washed 3 times in PBS to remove excess unbound GRP-78 and incubated with rabbit anti-GRP-78 antibody (1/2000) for 1 hour at room temperature. The plate was washed 3 times in PBS and incubated with antirabbit HRP conjugated secondary antibody (1/3000) for 1hour at room temperature. After washing 3 times with PBS, the plates were developed using the turbo TMB ELISA substrate (PIERCE) according to the manufacturer's protocol. For GRP-78 binding experiments with DMP1, 10µg/well of DMP1 was incubated with the collagen coated plates for 2 hours at room temperature to saturate the DMP1-collagen binding. The experiment was then performed as described previously with increasing concentrations of GRP-78.
In vitro binding experiment:
The in vitro binding of recombinant DMP1 to MC3T3 cells was carried out as published previously [25] .
Endocytosis of DMP1:
MC3T3-E1 cells, RMSCs or mouse primary calvarial cells were grown on cover slips placed in 6-well tissue culture dishes in their respective growth media for at least 24 h. Before the start of the experiment, the cells were washed with PBS and then incubated with 10µg/ml of FITC labeled DMP1 at 37 o C for 30min. FITC labeling was carried out as published previously [25] .
The cells were then washed extensively, fixed, permeablized and mounted on glass slides using mounting media with DAPI nuclear stain (Vector Labs). The cells were imaged using a Zeiss LSM 510 confocal laser scanning microscope.
Pull down assay to show DMP1 and GRP-78 interaction:
Membrane proteins from MC3T3-E1 cells were isolated using the MEM-per membrane protein isolation kit (PIERCE). The pull-down experiments were carried out as previously published [25] . Briefly, the membrane protein lysate was passed through a GST-DMP1 column. The column was washed extensively and the bound proteins were eluted under high salt conditions, dialyzed to remove salt, lyophilized and resolved by SDS-PAGE analysis.
Immuno-blotting was performed using anti-GRP-78 antibody (1/1000 dilution) and HRP conjugated anti-rabbit secondary antibody (1/3000 Cell Signaling). Lysate passed through GST column alone served as a negative control.
Greneration of plasma membrane patches:
Plasma membrane patches from MC3T3 cells were prepared as described previously [26] . The patches were fixed in 4% paraformaldehyde and immunostained with anti-GRP-78 antibody.
Immuno-staining and confocal microscopy:
For immuno-staining, MC3T3-E1 cells, primary calvarial cells RMSCs or cover glasses with ECM proteins or plasma membrane patches were fixed (after completion of the experiment) in 4% paraformaldehyde, permeablized and blocked with 5% bovine serum albumin (BSA) in PBS for 1 h at room temperature and incubated with the indicated concentrations of the primary antibody (1:100 anti-GRP-78 antibody, 1:100 anti-DMP1 antibody, 1:75 anti-caveolin1 antibody) overnight at 4 o C. After washing three times with PBS, the cells were incubated for 1 h at room temperature with the appropriate secondary antibody (1:100 anti-rabbit TRITC conjugate from SIGMA). All secondary antibody incubations were performed in the dark to minimize loss of fluorescent signal due to photo bleaching. The cells were then washed three times in PBS and mounted on glass slides for confocal microscopy.
GRP-78 shRNA knockdown:
Five target sequences of GRP-78 gene were tested for knock-down experiments. One sequence that was effective in silencing GRP-78 was used in this experiment. This sequence targeted mouse GRP-78 at the 3' untranslated region. MC3T3 cells were plated on to 6 well tissue culture plates at 80% confluence and allowed to attach for 24 hours. They were then transiently transfected with the GRP-78 shRNA plasmid pLKO.1 (Sigma) containing the sequence CCGGCTCGAATGTAATTGGAATCT TCTCGAGAAGATTCCAATTACATT CGAGTTTTT using Superfect (QIAGEN) transfection reagent as per the manufacturer's protocol. 24 hours post-transfection, the cells were incubated with 10µg/ml FITC-DMP1 for 10 minutes. The cells were fixed, permeablized and immuno-stained with anti-GRP-78 antibody as described previously. The cells were imaged using a Zeiss Axio Observer-D1 fluorescence microscope equipped with the appropriate filter sets to view green and red fluorescence and Axiovision imaging software. The fluorescence from the cells was quantified using the Axiovision software.
Localization of GRP-78 by Immunohistochemical
analysis: Embryonic day 13.5 (E13.5), 15.5 (E15.5), postnatal day 1 (P1), day 3 (P3), day 5 (P5) mouse heads and day 20 (P20) mouse jaws were sectioned along the midline and embedded in paraffin. Additionally, long bones of 4 week post natal mice were also embedded in paraffin.
Sections were cut at a thickness of 5μm. The P20 mouse jaw samples and 4 week long bone samples were demineralized before fixation and embedding.
The sections were deparaffinized with xylene and hydrated through graded ethanol. They were then incubated in 3% H 2 O 2 for 30 min to quench endogenous peroxidase activity and blocked with serum in PBS (Vecta stain ABC peroxidase kit) for 1 h at RT. Sections were then incubated overnight at 4°C with either 30μg/ml of biotinylated DMP1, or anti-GRP-78 antibody (1/100) in PBS containing 3% BSA. Slides were then washed 4× in PBS (15 min each wash). The sections that were incubated with the primary antibodies were incubated with their biotin conjugated secondary antibodies, washed 4x in PBS, incubated with peroxidase conjugated streptavidin (Vectastain ABC peroxidase kit) and developed with the DAB kit (Vector labs). All experiments were performed in accordance with approved UIC animal protocol (Assurance no: A3460.01).
Results: Expression of GRP-78 transcript and protein during differentiation in-vitro:
To study the expression of GRP-78 during differentiation, changes in GRP-78 mRNA and protein expression levels in mouse primary calvarial cells after culturing them in differentiation media for the indicated time points were examined. Figure 1A shows quantitative RT-PCR analysis of GRP-78 expression in mouse primary calvarial cell cultures for 7, 14 and 21 days. Figure 1B shows representative immuno-blots of GRP-78 protein expression and the corresponding tubulin expression in mineralizing primary calvarial cultures. Figure 1C is a quantification of immuno-blots (n=4) using the Image J software. An increase in the expression of RNA and protein was noted when the cells were differentiated in-vitro.
Presence of GRP-78 in the secreted media:
To determine if GRP-78 is a secretory protein western blot analysis was performed. Figures 1D shows immunoblots of the total secreted proteins isolated from MC3T3-E1 and mouse primary calvarial cells ( top two blots in Figure 1D ). GRP-78 was observed in the secretome of both cell types. The secretome was also tested for the presence of tubulin to rule out contamination from dead cells. No positive tubulin band was obtained (data not shown). Therefore, GRP-78 present in the secretome is not a product of apoptotic or lysed cells in culture. Additionally, in accordance with a published report [12] , GRP-78 was present in increasing amounts in the media of cells cultured in the presence of differentiation media [ Figure 1D ]. 21 day media from cells cultured in basal media served as control. To maintain consistency in loading, the volume of media extracted from the cells, the volume of reconstitution and the loading volume were maintained constant.
Detection of GRP-78 in the ECM of MC3T3-E1 cells:
The ECM of MC3T3-E1 cells was stained for with GRP-78 antibody. Figure 1E shows positive staining for GRP-78. The presence of sheared DNA smeared on the surface indicated by DAPI nuclear stain confirmed that the cells have been successfully lysed. Figure 1F is a negative control showing the absence of non-specific staining from the fluorescent secondary antibody and Figure 1G shows that the positive staining obtained in 1E is not due to cell debris as the cell debris was found to fluoresce non-specifically in both red and green channels.
Binding of GRP-78 to type I collagen:
To demonstrate a function for GRP-78 during mineralized matrix formation, a solid-phase binding assay was performed to characterize the interaction between GRP-78 and type I collagen. Results in Figure 2A show the inverse Langmuir isotherm for GRP-78 binding to type I collagen. The dissociation constant was estimated to be 34 nM. The binding of GRP-78 to type I collagen was also verified in the presence of DMP1 bound to type I collagen. The rationale was to mimic the ECM environment when both DMP1 and GRP-78 are available to bind to type I collagen. The ability of DMP1 to bind to type I collagen and aid nucleation of hydroxyapatite has been shown previously [19] . Results showed that GRP-78 bound type I collagen first as it had a higher binding affinity (comparing data from figures 2A and 6) and then to the DMP1 bound to type I collagen ( Figure 2B) . Additionally, the isolated secreted pool of proteins from MC3T3-E1 cells cultured in growth media and differentiation media for 21 days when incubated with type I collagen coated plates showed that secreted GRP-78 was able to bind to type I collagen and that the secreted pool of proteins from mineralized cell cultures contained a higher concentration of GRP-78 (Fig 2C) .
In-vitro nucleation of calcium phosphate crystals by GRP-78:
Published studies demonstrate that GRP-78 binds intracellular calcium [10] . We investigated if immobilized GRP-78 had the potential to bind calcium and nucleate calcium phosphate crystals in vitro. To test this, recombinant GRP-78 immobilized on glass substrate was subjected to an in vitro nucleation assay. Uncoated cover glass and cover glass coated with BSA served as controls. Results in Figure 3A & 3A1 showed no calcium phosphate deposits on uncoated cover glass control. Mineral deposits were observed with BSA and GRP-78 ( Figures 3B, 3B1 In-vitro mineralization experiments confirmed that GRP-78 coated dentin wafers facilitated deposition of calcium phosphate polymorphs ( Figure 5 ). No nucleation was observed in uncoated and BSA coated wafers. The average calcium to phosphate ratio was 1.86 (n=3, SD=0.22).
Developmental expression pattern of GRP-78:
To study the developmental expression of GRP-78 protein in intramembranous and endochondral bone matrix, immunohistochemical analysis was performed. Results in Figure 6 show strong positive staining for GRP-78 in cells producing a mineralized matrix (chondrocytes as well as osteocytes) (black arrows). The sections also showed the presence of GRP-78 in the bone matrix (white arrows).
As expected, GRP-78 expression was observed both during early and late bone development. Figure   6G and 6H are secondary antibody negative controls.
DMP1cell surface binding and endocytosis:
To elucidate DMP1 binding to mesenchymal cells, we performed binding assays at 4 o C to prevent endocytosis in MC3T3-E1 cells. Figure  7A shows the inverse Langmuir isotherm plot of the data from the binding experiment demonstrating that the binding of DMP1 to MC3T3-E1 cells was saturable. The dissociation constant was estimated to be 120 nM. We show that incubating MC3T3-E1 cells at 37˚C with FITC labeled DMP1 facilitates endocytosis ( Figure 7B ) of DMP1. This was also observed in primary calvarial osteoblasts ( Figure 7C ) and RMSCs ( Figure 7D ). Longer incubation periods (45 to 60 minutes) at 37ºC resulted in nuclear translocation of the endocytosed DMP1. Figure 7E shows a representative experiment with nuclear localization of endocytosed FITC-DMP1 in MC3T3-E1 cells.
GRP-78 on the plasma membrane functions as a receptor for DMP1 endocytosis:
To confirm if the endocytosed DMP1 co-localized with GRP-78, immunostaining was performed on MC3T3-E1 cells with anti-GRP-78 antibody after endocytosis of FITC-DMP1. Figures 8A  and 8B show the co-localization of GRP-78 with DMP1 in MC3T3-E1 cells ( Figure 8A ) as well as in primary calvarial osteoblasts ( Figure 8B ). The yellow regions in Figure 8A and 8B indicate endocytic vesicles with colocalization of FITC-DMP1 and GRP-78. To elucidate the presence of GRP-78 on the plasma membrane, plasma membrane patches were prepared and immuno stained with GRP-78 antibody. The boxed region in Figure 8D shows a plasma membrane patch positively stained with GRP-78 antibody the absence of nuclear staining compared to neighboring cells indicates an intact plasma membrane patch. To elucidate association of DMP1 with GRP-78 on the plasma membrane, membrane protein lysates from MC3T3-E1 cells were passed through a DMP1 column and the bound proteins were isolated. Figure 8C shows an immunoblot with anti GRP-78 antibody performed on the eluate from the column. GST beads alone did not show any reaction to GRP-78 antibody under identical experimental conditions (data not shown).
To confirm GRP-78 as a receptor for DMP1 in osteoblasts, the expression of GRP-78 was knocked down by means of shRNA in MC3T3-E1 cells. Figure 8E is a graphical representation of FITC-DMP1 intensity and GRP-78 intensity obtained by quantification of fluorescence from cells transiently trasfected with GRP-78 shRNA and subjected to FITC-DMP1 endocytosis. The intensity of endocytosed FITC-DMP1 was proportionally reduced upon GRP-78 knockdown.
Involvement of caveolae in the endocytic process mediated by GRP-78:
We previously showed that endocytosis of DMP1 occurs via the caveolar endocytic pathway in odontoblasts [25] . Therefore, we investigated if the same endocytic route was adopted in osteoblasts. Figure 8F is a confocal micrograph that shows co-localization of endocytosed FITC-DMP1 and caveolin-1 in MC3T3-E1 cells. Co-localization of caveolin-1 and FITC-DMP1 are shown in regions marked yellow. The arrows and circled regions in Figure 8F indicate vesicles that show co-localization of FITC-DMP1 and caveolin-1. Figures  8G and 8H are enlarged images of Figure 8F that show co-localization.
Discussion:
GRP-78 has been shown over the years to be involved in several cellular functions apart from functioning as a molecular chaperone in the endoplasmic reticulum. GRP-78 expressed on the cell surface functions as a receptor for a wide variety of ligands and is a signaling receptor for activated alpha2-macroglobulin [8] . It plays a critical role in viral entry of Coxsackie B and Dengue viruses [6] [7] [8] [9] . Recent studies have demonstrated GRP-78 as a secretory protein [1, 12] indicating a possible extracellular function for GRP-78. One study points to an extracellular role of GRP-78 in the zona pellucida regulating the penetration of sperm by modulating calcium ions [29] . Recently, a role for extracellular GRP-78 has been identified in the regulation of inflammatory cytokines [30] . These studies indicate that GRP-78 is a multifunctional protein with a calcium binding property [10] that can possess extracellular functionality. Despite extensive studies, a role for GRP-78 in skeletal development has not been explored. In this study, we showed that GRP-78 is localized on the plasma membrane of osteoblasts and in the mineralizing matrix of osteoblasts and bone, indicating a regulatory function during mineralized matrix formation. Localization of GRP-78 in the bone matrix during development indicates a functional role for GRP-78 during mineralization.
We recently showed that DMP1 is endocytosed by pre-odontoblasts and DPSCs (dental pulp stem cells) by binding to GRP-78 receptor and is translocated to the nucleus [25] . Although odontoblasts and osteoblasts possess similar characteristics, differences exist between the two cell types. For example, the two cell types differ in their response to BMP and TGFβ stimulation. BMP/TGFβ stimulation triggers expression of RUNX2 and its target genes in osteoblasts.
However, the same response in odontoblasts is triggered by fibroblast growth factor family of proteins (FGFs) [28] . It was therefore necessary to study the involvement of GRP-78 in the endocytosis of DMP1 in osteoblasts. In the present study, we show that the process of endocytosis of DMP1 is not limited to odontoblasts and occurs in preosteoblasts and osteoblasts as well. Down regulation of GRP-78 by shRNA correspondingly reduced the amount of internalized DMP1 confirming its role in receptor-mediated endocytosis of DMP1. To determine whether endocytosis is facilitated by GRP-78 localized on the cell surface, MC3T3 cells were analyzed for the presence of GRP-78 on the membrane. Our studies revealed the presence of GRP-78 on the cell surface. Published reports demonstrate that a subpopulation of GRP-78 exists constitutively as a transmembrane protein; therefore, it is possible that GRP-78 can be found constitutively on the plasma membrane of osteoblasts and pre-osteoblast cells. In addition to its role as a cell-surface receptor, we have identified GRP-78 as a secreted protein in the secretome of MC3T3-E1 cells and primary calvarial osteoblasts. We demonstrate that during in vitro differentiation there is an increase in the expression levels of GRP-78 in primary calvarial cells. This observation corroborates well with the published report showing expression of GRP-78 on the plasma membrane as well as in the culture medium of rabdomiosarcoma cells [1] . Recently, GRP-78 has also been reported to be present in the secretome of mesenchymal stem cells and the expression levels increased upon differentiation [12] . Further, we demonstrate that higher amounts of GRP-78 from the secreted media of mineralizing cells bound to type I collagen. Increased secretion of GRP-78 protein could also be a reason for the drop in intracellular protein levels at the 21 day time point in mineralizing calvarial cell cultures.
Collectively, these experiments show that eventhough GRP78 is predominantly expressed as an intracellular protein residing in the ER lumen; however, our experimental approaches indicate that GRP-78 is also present in the secretome of differentiating osteoblasts.
To identify a function for GRP-78 in the ECM of mineralizing cultures, we show that GRP-78 can bind type I collagen. The binding was specific with a binding constant of 34nM. In the presence of type I collagen bound with DMP1, we observed a two phase binding curve. The first phase represented GRP-78 binding to type I collagen with saturation concentration similar to that of type I collagen-GRP-78 binding by itself. The second phase is the binding of GRP-78 to DMP1 bound to the type I collagen. This result shows that the presence of DMP1 does not alter the binding of GRP-78 to type I collagen and that GRP-78 would bind to DMP1 after saturating its type I collagen binding. In the ER, GRP-78 has been shown to bind to procollagen along with other heat shock proteins [31] at the C-terminal propeptide region. This result corroborates well with a published report that indicates that GRP-78 binds gelatin [32] . Collectively, it can be surmised that extracellular GRP-78 could potentially bind to both type I collagen and DMP1 bound to type I collagen.
GRP-78 is known to function as a Ca 2+ binding protein [10] and this might implicate another role in the extracellular matrix during calcified tissue formation. In vitro nucleation experiments demonstrate that GRP-78 immobilized on a glass substrate had the potential to nucleate calcium phosphate. In bone, hydroxyapatite nucleation and growth is initiated on a type I collagen scaffold. Therefore, we explored if GRP-78 immobilized on a collagen substrate or to demineralized dentin wafer would initiate nucleation of calcium phosphate. Results from this study showed the nucleation of amorphous calcium phosphate polymorphs. Demineralized dentin wafers are not substitutes for demineralized bone, however, they mimic the in vivo type I collagen scaffold.
During the process of biomineralization, regulation of calcium ions is of utmost importance and their regulation by calcium sequestering proteins in the ECM play a central role in the nucleation of calcium phosphate. Upon analysis of our results, it is tempting to speculate that GRP-78 might function in maintaining a local reservoir of calcium ions in the ECM during bone formation. This speculation is further strengthened by the developmental expression pattern of GRP-78 that shows increased expression in cells such as hypertrophic chondrocytes, osteoblasts, osteocytes and in the bone matrix.
A recent study by Murakami et al. has shown the involvement of the endoplasmic reticulum stress transducer OASIS in the formation of bone [25] . This report iterates novel roles for endoplasmic reticulum stress proteins in bone formation. We believe that our finding will open new doors in understanding the multifunctional roles of these stress response proteins in calcified tissue formation. In conclusion, the following functions for GRP-78 could be envisaged during bone formation apart from its chaperone function in the ER: (1) Extracellular GRP-78 in the matrix can specifically bind to type I collagen and/or DMP1 and sequester Ca 2+ ions and aid in the nucleation of calcium phosphate polymorphs. (2) Cell surface GRP-78 could mediate endocytosis of DMP1 leading to subsequent signaling events. This study, on the role of GRP-78 in mineralized matrix formation will unravel mechanisms that would improve our understanding of mineralized tissue formation such as bones and teeth. In-vitro nucleation of calcium phosphate by GRP-78 bound to demineralized dentin wafers: (A), (A1) Electron micrograph of control demineralized dentin wafer subjected to in vitro nucleation and its corresponding EDX analysis respectively. Scale bar represents 1µm in (A). (B), (B1) Electron micrograph of BSA incubated with demineralized dentin wafer subjected to in vitro nucleation and its corresponding EDX analysis. Scale bar represents 1µm in (B). (C), (C1) Electron micrograph of GRP-78 incubated with demineralized dentin wafer subjected to in vitro nucleation and its corresponding EDX analysis. Scale bar represents 1µm in (C). White arrows point to calcium and phosphorous peaks. 
